immunoassays. Chemical methods of analysis thus owe much to natural bioreceptors, as well as to group reagents, chelating agents, and various supramolecular receptor molecules developed by organic chemistry. Binding assays are typically used. Conventional binding assays can neither discriminate agonists from antagonists nor give sufficient information on their physiological activities. The physical methods such as NMR and MS cannot provide this informaiton either. The bioassay using intact biological tissue or whole bodies has a unique position in analysis, because it can target bioactive substances. However, the bioassay cannot give molecular level information because of its inherent "black box" approach.
During the past 50 years, molecular biology has developed mostly by taking advantage of physical and chemical methods of analysis, and has thereby contributed to elucidate the molecular chemistry behind the cellular mechanism.
If analytical methods for bioactive substances are based not only on binding to receptors but also on the following known molecular level processes of signal transduction in respective signaling pathways, reconstructed in vitro or taken in part in vivo, they will give the physiologically relevant selectivities of the analytes in terms of cellular mechanisms at the molecular level. This is of prime importance for screening and targeting pharmaceutically, toxicologically and environmentally relevant bioactive substances. Chemical analysis methods for bioactive substances thus will rely more and more on molecularrecognition and cellular signal transduction, mimicking how living things on earth "see" ions and molecules. 1 
Transmembrane
Signaling:
Ion-Channel Sensors and Active Transport Sensors
When we initiated in the late 80s some work to develop ionchannel sensors 2 and active (uphill) transport sensors [3] [4] [5] [6] as new analytical sensors, our aim was still only to gain high sensitivity. Therefore, we even took an approach of mimicking functions of receptor ion-channel proteins and cotransporter proteins, using synthetic molecules. Since the first report of ion-channel sensors of this biomimetic approach in 1987, 2 over 200 related works have appeared based on the same sensing concept. [7] [8] [9] [10] [11] A membrane-protein-based ion-channel sensor for glutamate and active (uphill) transport sensor for glucose were first reported later in 1990 and 1993, respectively. [12] [13] [14] [15] Coulometric biosensors using glutamate receptor (GluR) ion channel protein as a signal-amplifying sensory element that exploits the glutamate-triggered Na + ion current through bilayer lipid membranes have been fabricated. 13 The formation of stable planar bilayer lipid membranes was achieved by applying the folding method across a small circular aperture bored through a thin polyimide film. The multichannel type sensing membranes, formed across an aperture of ca. 120 µm diameter, contained more than 10 GluR proteins and showed L-glutamatetriggered response as a composite of individual single-channel currents. The single-channel type sensing membranes, formed across an aperture of ca. 20 µm diameter, contained a sufficiently small number of GluR proteins so that the response was observed as a series of single-channnel pulse currents. Dependence of the integrated channel current on the glutamate concentration was examined.
A sharp concentration dependence of up to ca. 1.5 × 10 -7 M and 3 × 10 -6 M was observed for the multichannel and single-channel type sensors, respectively. The selectivity for inducing the channel current was higher for L-glutamate than for D-glutamate. A detection limit as low as ca. 3 × 10 -8 M was attained for the multichannel type sensor, which was eventually improved down to 0.10 × 10 -9 M. 16 This remarkable sensitivity was discussed in terms of the potential use of GluR ion channel proteins for a new type of sensing system.
A new type of amperometric biosensor for glucose was fabricated using an Na + /D-glucose cotransporter as the signaltransducing sensory element that exploits the D-glucosetriggered Na + ion current through bilayer lipid membranes (BLMs). 14 The planar BLM was formed by the folding method across a small aperture of a thin Teflon film. The Na + /Dglucose cotransporter, isolated and purified from small intestinal brush border membranes of gulinea pigs, was embedded into BLMs through proteoliposomes. The number of the protein molecules thus incorporated in the present sensing membrane was estimated to be ca. 10 7 . The sensor response was measured as an ionic current through the BLM arising from cotransported Na + ion flux under a constant applied potential and was only induced by D-glucose above 10 -9 M, but not by the other monosaccharides except for D-galactose. The effects of applied potentials, Na + and K + ion concentrations, and the addition of a competitive inhibitor, phlorizin, were scrutinized to characterize the sensor output. The results were briefly discussed in terms of the potential use of the Na + /D-glucose cotransporter as a sensory element for D-glucose.
We relied on the functions of transmembrane signaling to gain high sensitivities for the above glutamate ion-channel sensor and glucose uphill transport sensor. However, we still did not explicitly notice in the earlier stage of the works that the intensity or extent of signal transduction is not necessarily proportional to the strength of initial receptor binding, excluding the obvious case of antagonist.
Beyond Receptor Binding Assay
In the course of the study of these ion-channel sensors, the agonist selectivity based on the binding affinity for an NMDA receptor ion-channel was found to be different from the one measured as the number of ions passed through its channels. [16] [17] [18] The agonist selectivity in terms of the extent of such signal transduction thus turned out not to be parallel to the binding selectivity. Evaluating this signal transduction with respect to each agonist was thought to be of pharmaceutical significance for controlling neuronal transmission.
In the past several years, we have been studying analytical methods for bioactive substances. The methods are based not only on binding to receptors but also on the cellular signaling pathways. The idea is to explore new screening and targeting methods that can evaluate physiologically more relevant selectivity of analytes.
These analytes include pharmaceutically, toxicologically, and environmentally relevant chemicals.
3·1 Detecting
protein-phosphorylation-based insulin signaling pathways Insulin signaling pathways are initiated by binding of insulin to cell-surface insulin receptor. The insulin receptor is a heterotetrameric transmembrane glycoprotein, consisting of two α subunits and two β subunits linked together by disulfide bonds. Upon binding of insulin to the extracellular α subunit, insulin stimulates kinase activity of the insulin receptor and phosphorylates tyrosine residues of an intracellular substrate protein, insulin receptor substrate 1 (IRS-1). The tyrosine phosphorylation domains in IRS-1 are recognized by   504  ANALYTICAL SCIENCES MAY 2002, VOL. 18 corresponding Src homology 2 (SH2) domain-containing enzymes such as phosphatidylinositol 3′-kinase (PI 3-kinase).
The tyrosine phosphorylated IRS-1 plays key roles in on/off switching of the insulin signaling pathways, serving as an interface between insulin receptor and SH2 domain-containing enzymes, which mediate insulin-induced biological responses such as glucose uptake or cell proliferation (Fig. 1) . We have reported assay methods for evaluating agonist selectivity for the insulin signaling pathways. Agonist-induced phosphorylation of the substrate peptide by insulin receptor was evaluated by colorimetric assay 19 or by surface plasmon resonance spectrometry 20 with the SH2 domain of PI 3-kinase. By these methods, vanadium ions and troglitazone have been found to induce insulin-like effects without affecting kinase activity of insulin receptor and binding activity of SH2 domain of PI 3-kinase. Furthermore, it has been revealed that insulin receptor accommodated by insulin, insulin-like growth factor I (IGF-I), or insulin-like growth factor II (IGF-II) exhibited different kinase activities. The order was found to be insulin > IGF-I > IGF-II, whereas the order of Kd value has been reported to be insulin > IGF-II > IGF-I. 3·1·1 Chemical selectivity of agonists for insulin signaling pathways based on agonist-induced phosphorylation of a target peptide 19 A new assay method was described for evaluating agonist and antagonist selectivities for the insulin signaling pathway, which was based on the on/off switching mechanism of the insulin receptor-mediated insulin signaling described above. The principle is schematically shown in Fig. 2 . 19 Insulin receptor serves as a primary receptor for insulin and Y939 as a target peptide. The Y939 peptide, a synthetic peptide of 12 amino acid residues, consists of a tyrosine-phosphorylated domain of IRS-1 and of a binding domain of IRS-1 to PI-3 kinase. The Y939 peptide is immobilized on an avidin coated 96-well microtiter plate (Step 1 in Fig. 2 ). Upon binding insulin to its receptor, insulin stimulates its receptor kinase activities in a sample solution and phosphorylates the tyrosine residue of the Y939 peptide immobilized on the well surface (Step 2 in Fig. 2 ). The sample solution is washed out, and a selective binding protein for the phosphorylated tyrosine, monoclonal antiphosphotyrosine antibody labeled with horseradish peroxidase, is added and a phosphorylated peptide-antibody complex (Step 3 in Fig. 2 ) is formed. The amount of the complex thus formed was detected by enzymatic amplification with horseradish peroxidase that can produce a green-color product with an absorbance at 727 nm capable of being detected by colorimetry. The amount of the phosphorylated Y939 peptide thus measured is expected to be a selective and sensitive measure of the extent of the insulin signaling, representing the physiologically more relevant selectivity for agonists and metal ions such as vanadium ion.
An insulin-dependent absorbance was observed for insulin concentrations from 1.0 × 10 -10 M to 1.0 × 10 -7 M, above which it leveled off. The observed absorbance was explained as due to an increase in the phosphorylated Y939 peptide caused by insulin and its receptor complexation. No signal was induced by either vanadyl or vanadate ions at concentrations up to 1.0 × 10 -4 M; these results and previous intact cell level data taken together allow us to conclude that these ions did not induce phosphorylation of the Y939 peptide. Upon addition of tyrphostin, a specific inhibitor for insulin receptor kinase activity, phosphorylation of the Y939 peptide in the presence of 1.0 µM of insulin was competitively inhibited over 1.0 × 10 -4 M tyrphostin. The present system thus exhibited "physiologically more relevant" agonist and antagonist selectivity. The principle is based on part of the insulin signal transduction, rather than simply relying on the binding assay. 3·1·2 An SPR-based screening method for agonist selectivity for insulin signaling pathways based on the binding of phosphotyrosine to its specific binding protein 20 of PI-3 kinase (SH2N), were detected by surface plasmon resonance (SPR) spectrometry. This method is based on competitive binding of SH2N to pY939 either in a solution or on the gold surface of the SPR sensor chip. When the concentration of pY939 in solution increases due to the insulininduced kinase reaction of insulin receptor, SH2N bound to this solution pY939 increases and the one on the sensor chip decreases, thereby causing the decreased SPR signal (Fig. 3) . 20 The amount of complex of pY939 thus detected with SH2N was found to depend on added insulin concentrations, confirming that the method utilized part of the sequential transduction mechanism of the insulin signaling pathways. The kinase activity of insulin receptor-agonist complexes increased in the order of IGF-II < IGF-I < insulin, and neither vanadium ions nor thiazolidine type medicines for NIDDM, troglitazone and pioglitazone, directly acted on both the kinase reaction of insulin receptor and the binding of pY939 to SH2N. The present approach will thus become a general method for screening agonists for one specific pathway in tyrosine phosphorylation of IRS-1 in insulin signaling, which is regulated by specific protein-protein interaction between a phosphorylated tyrosine in IRS-1 and its corresponding SH2 domain-containing protein such as PI-3 kinase, Grb2-SOS and SHP2. Formation of an F-SH2N-T-pY939 complex (termed as a FRET pair) was evaluated from a change in a fluorescence emission spectrum based on fluorescence resonance energy transfer (FRET) between the two fluorophores. The FRET pair was formed to dissociate in competition with the unlabeled pY939 phosphopeptide, resulting in a decrease in a pY939 phosphopeptide-dependent FRET emission at 580 nm and causing an increase in emission at 520 nm. Tyrosine phosphorylation by partially purified insulin receptor of substrate peptide Y939 was detected with this formed FRET pair, and resulting changes in fluorescence emission spectra were observed for insulin concentration from ca. 1.0 × 10 -9 to 1.0 × 10 -6 M. These results indicated that the FRET pair served as a competitive fluorescent indicator for tyrosine phosphorylation-based insulin signaling.
We have also used mutants of green fluorescent protein (GFP), CFP and YFP, for synthesizing genetically encoded fluorescent indicators for the same purpose as the above, which will be described elsewhere (see 4·1).
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ANALYTICAL SCIENCES MAY 2002, VOL. 18 3·2 An optical method for evaluating ion selectivity for calcium signaling pathways in the cell 22 Calcium ions play an important role as a messenger in cellular signal transduction pathways. In order to detect the Ca 2+ signal in cells, nature has developed a number of proteins to selectively or specifically recognize Ca 2+ . Among many Ca 2+ -sensor proteins, calmodulin (CaM: 148 amino acid residues 16.7 kDa) is a ubiquitous Ca 2+ binding protein which serves as a multifunctional Ca 2+ sensor in a variety of cellular processes such as energy and biosynthetic metabolism, cell motility, exocytosis, cytoskeletal assembly and intracellular modulation of both cAMP and Ca 2+ concentrations. CaM has four Ca 2+ binding sites within two helix-loop-helix (EF-hand) motifs, organized in two structurally similar globular domains. One of the EF-hands has high-affinity sites with binding constants for 2+ binding proteins to interact (bind) with the target proteins and this binding leads to the activation and regulation of the latter. The mechanism by which CaM recognizes the target protein has been defined by crystallography, NMR, and other spectroscopic studies combined with site-directed mutagenesis of CaM; the CaM-Ca 2+ complex can bind to the CaM-binding domains of all its target proteins with high affinity, despite their lack of amino acid sequence homology. The only common feature is that they are hydrophobic basic peptides that have a propensity to form an α-helix. If the molecular mechanisms of such a fine tuning of protein conformation are introduced into a sensing system, which is responsible for a Ca 2+ -dependent on/off switch for cellular processes, then physiologically more relevant ion selectivity, i.e., agonists or antagonists toward Ca 2+ signaling pathway via CaM may be evaluated.
We have developed an optical method for evaluating such ion selectivity for Ca 2+ signaling pathway based on the above described on/off switching mechanism of the CaM mediated Ca 2+ signaling, which is monitored by surface plasmon resonance (SPR). The principle is schematically shown in Fig.  5 . 22 CaM serves as a primary receptor for Ca 2+ ion and M13 as a target peptide. The selective binding of CaM to M13 in the presence of Ca 2+ or other possible interfering ions is monitored by SPR technique. M13 is a synthetic peptide of 26 amino acid residues, comprising a CaM-binding domain (residues 577 to 602, its dissociation constant with CaM is 1 nM) of skeletal muscle myosin light-chain kinase (MLCK).
M13 is immobilized covalently on the dextran matrix attached to the gold surface. Upon binding four Ca 2+ ions, CaM in the sample solution undergoes conformational changes to form a CaM-Ca 2+ complex. The complex thus formed is then bound to the immobilized target peptide M13, and forms a CaM-Ca 2+ -M13 ternary complex in the dextran matrix, which is measured by surface plasmon resonance (SPR), a technique which sensitively responds to changes in the refractive index close to a gold surface. The amount of the ternary complex thus formed is expected to be a selective and sensitive measure of the extent of the Ca 2+ signaling, representing the physiologically more relevant selectivity of metal ions.
The present SPR method thus provided metal ion selectivity for Ca 2+ signaling pathways based on selective binding of CaM with Ca 2+ and resulting binding of the Ca 2+ -CaM complex with the target peptide, M13. Metal ions with ionic valences of +2 or +3, Cd 2+ , Pb 2+ , Sr 2+ , Ba 2+ , and Y 3+ , and lanthanide ions, of which the ionic radii are nearly equal to or higher than that of Ca 2+ , induced the formation of the CaM-metal-M13 ternary complex. 23 Using another calcium binding protein, recoverin, we verified the relationship between the conformational change of recoverin induced by binding of metal ions and the coordination structures of metal-bound recoverin using SPR technique and FT-IR spectroscopy. 24 Prior to evaluation of substrate phosphorylation by insulin receptor, the fluorescein-labeled SH2N (F-SH2N) and tetramethylrhodamine-labeled pY939 (T-pY939) are mixed to form the F-SH2N-T-pY939 complex (FRET pair), where fluorescence resonance energy transfer (FRET) is induced between the two fluorophores. The FRET pair injected into a kinase reaction solution or in an insulin-stimulated living cell dissociates in competition with the tyrosine phosphorylated substrate, resulting in disappearance of this FRET mode. 21 On the other hand, Mg 2+ -loaded EF-hand domains of recoverin take six coordination structure, that is, unidentate coordination to COO -of Glu in the EF-hand, and the myristoyl group remains sequestered. In the resting state of eukariotic cells, Mg 2+ binds to the Ca 2+ -binding loop of EF-hands to some extent, but the overall conformation is "closed" as for the ionfree recoverin, since the smaller Mg 2+ does not allow the side chain carboxylates of the Glu in the 12th loop position into the coordination sphere. Our results support the hypothesis that the Glu residue at the 12th position of the EF-hand operates as an essential residue in Ca 2+ /Mg 2+ exchange; the coordination requirement of one of the two physiologically relevant ions, Ca 2+ , can be met upon binding to the protein with major rearrangement of the conformation, while Mg 2+ ion, on the contrary, cannot fulfill this requirement. This solves the long standing question of how Ca 2+ can selectively activate recoverin in the presence of Mg 2+ . 24 The present approach will provide a means of evaluating toxicological effects of not only metal ions but also organic compounds on the Ca 2+ signaling pathway through CaM. However, after thus screening and evaluating each metal ion or agonist by the present method, actual toxicological studies need to be substantiated with some in vivo systems, e.g., by measuring the level of biomarkers such as concentration or activity changes of specific target enzymes when animals are exposed to the ions or organic compounds.
The same system was likewise used for the screening of specific inhibition of the protein-protein interaction in the Ca 2+ -signaling pathways (Fig. 6) . 25 The decrease in the binding of Ca 2+ -CaM to M13 by the binding of Ca 2+ -CaM to its antagonists was monitored by SPR, in view of finding antagonists that inhibit the interaction between Ca 2+ -CaM and MLCK that is essentially represented by M13. This system is not for detecting interaction of Ca 2+ -CaM with the antagonists, but for detecting the process by which the relevant antagonists inhibit the binding of Ca 2+ -CaM to M13. By replacing the immobilized M13 with other target peptides having a binding domain of particular proteins, it is possible to similarly examine whether given antagonist candidates inhibit the interaction between Ca 2+ -CaM and each corresponding target protein. Additionally, in the case that a given target protein has multiple binding sites, the use of its binding domain rather than the actual target protein itself permits one to screen antagonists based on binding-site specific inhibition of the Ca 2+ -CaM-target protein interaction. This assay method is thus able to find antagonists that uniquely suppress the interaction between Ca 2+ -CaM and each particular target protein including specific binding domains.
Recently, the progress of molecular biology allows identification of many disease-related biological pathways. Therefore, by using the present new screening method, it may be possible to screen drug candidates that inhibit only diseaserelated pathways, leading eventually to the development of drugs essentially devoid of side effects. Furthermore, the present approach provides a method for evaluating toxicological effects of a variety of chemical compounds that may inhibit interactions between Ca Fig . 6 Principle of the present screening method for antagonists that inhibit a physiologically relevant Ca 2+ -signal transduction. When a CaM antagonist is added in a sample solution and binds to Ca 2+ -CaM complexes, the amount of Ca 2+ -CaM complexes bound to immobilized M13 decreases, and the observed SPR signal is reduced, as a result. 25 
Probing Cellular Signaling Pathways in Living Cells
For nondestructive analysis of chemical processes in living cells, fluorescent probe molecules have been developed for second messengers Ca 2+ and cAMP, and for ions and small molecules such as Na + , K + , Zn 2+ , Mg 2+ , Cl -and NO. In addition, green fluorescent protein (GFP) and its analogous proteins have been used to probe proteins as to their structural and locational changes of proteins, upon genetically labeling them to proteins of interest. However, many intracellular chemical processes and cellular signaling processes are still studied basically by relying on destructive analysis by disrupting hundreds of thousands of cells, followed by separation, purification and detection of intracellular components.
Therefore, methods for direct nondestructive analysis of cellular signaling steps in live cells are now required.
Intercellular signaling substances (first messengers) include neurotransmitters, cytokines and hormones functioning in nerve, immune and endocrine systems. These substances bind either to ion-channel, kinase or G protein-coupled membrane receptor proteins, and trigger the respective down-stream intracellular signaling.
For this intracellular signaling, we have developed some general methods and new intracellular fluorescent probes for detecting 1) second messengers, cGMP, diacylglycerol (DAG), and phosphatidylinositol-3,4,5-triphosphate (PIP3), 2) protein phosphorylation, 3) protein conformational change (kinases etc.) and 4) protein-protein interactions, in live cells under a confocal laser fluorescence microscope (Fig. 7) . A method for detecting activation for G protein-coupled receptors is also being explored at the moment.
The developed probes for each particular signaling pathway, (1) -(4), have revealed physiologically relevant responses to respective ligands and agonists in live target cells.
The approach to the present probe developments is twofold: 1) use of fluorescence resonance energy transfer (FRET) for reporting binding of substrates (analytes) to molecular recognition domains in dual-fluorophore conjugated probe molecules, and 2) use of protein splicing chemistry for detecting protein-protein interactions. The methods for the probes 1) to 4) are generally applicable to any cells upon being tailor-made in target cells.
Therefore, these probes are of general importance not only for fundamental study of biology, but also for assay and screening methods for chemicals that inhibit or facilitate cellular signaling pathways. 26 4·1 Assay and screening of chemicals that disrupt cellular signaling pathways 27 To date, the number of synthetic molecules that are potentially harmful to the physiology of animals and plants is more than one hundred thousand, including pesticides and industrial chemicals, and the number continues to increase. One of the central issues regarding these chemicals is their possible endocrine-disrupting effects.
The purpose of analysis of these potential endocrinedisrupting chemicals (EDCs) is twofold: (I) their identification and quantitative analysis, and (II) risk assessment of each EDC candidate with respect to reproductive and developmental problems posed to animals and humans.
Recently, the International Union of Pure and Applied Chemistry, IUPAC, made a comprehensive survey of natural and anthropogenic environmental estrogens in relation to their scientific basis for risk assessment. Environmental Protection Agency, EPA, and Organization for Economic Cooperation and Development, OECD, have summarized the methods so far used for risk assessment of EDCs on animals and humans, and have proposed a series of screening tests to identify potential endocrine disruptors. 28, 29 EPA recommends prescreening using binding and reporter gene assays, followed by a secondary screening with TIER1 and the final test with TIER2, both based on bioassays. OECD also recommends dual approaches, using in vivo animal tests and in vitro screening, basically the same in principle as those of EPA. 28 The initial prescreening should have a high throughput, because the number of synthetic 509 ANALYTICAL SCIENCES MAY 2002, VOL. 18 molecules that are potential EDC candidates is large. For this high throughput prescreening (HTPS), α-, and β-estrogens, and androgen receptors are typically used in both binding and reporter gene assays. 30, 31 The receptor binding assay for estrogens and androgens is based on the competitive binding of these hormones to estrogen and androgen receptors, respectively. The reporter gene assay for steroid hormones is a serial or double binding assay, in which a steroid-hormone-bound steroid receptor is further bound to a promoter region of a gene to form a functional transcription factor that switches on a reporter gene. These two assay methods are now representative of HTPS for the risk assessment of EDC candidates.
The advantage of receptor binding and reporter gene assays is that they are quite simple to perform and allow the identification of all endocrine disrupters that act through the estrogen receptor. However, in the case of the binding assay, the binding selectivity does not necessarily represent the expected physiologically relevant selectivity. Antagonists and agonists cannot be discriminated; the efficacy of agonists will also depend on the extent of increase or decrease in the subsequent cellular signaling. In the reporter gene assay, use of artificial reporter genes naturally results in gene expressions different from those of endogenous ones and in biased output of physiological consequence with respect to risk assessment of EDCs.
Moreover, EDC candidates such as methylmercury and tributyltin, which do not exert effects via nuclear receptors, may not be detectable by receptor binding assay nor by reporter gene assay; that is, targets (receptors) of synthetic molecules may not necessarily be nuclear transcription factors such as estrogen and androgen receptors. EDC candidates that exhibit positive responses in these HTPS are then subject to in vivo bioassays (animal tests) based on TIER1 followed by TIER2. 28 In view of the above-mentioned circumstances, there is a need to develop a new HTPS method that is in contrast to the conventional receptor binding and reporter gene assays. The key concept of this method is that the measure of risk assessment should be based on the extent of changes in relevant cellular signaling pathways and/or gene expressions upon loading EDCs candidates to target cells. A living target cell is stimulated by EDC candidates and the resulting changes in relevant key steps in cellular signaling pathways are directly measured in vivo using fluorescent probe molecules for cellular signaling pathways. For the purpose of nondestructive analysis of key steps in cellular signaling pathways, we have so far developed fluorescent probe molecules for second messengers such as cyclic GMP and lipid messengers, activation of Ca 2+ signaling, protein phosphorylation, and protein-protein interactions.
Steroid hormones such as estrogens and androgens are known to bind to their receptors, the complexes of which are transported into the nucleus to control the expression of genes. This is the so-called genomic or classical pathway for steroidhormone signaling.
Recently, nongenomic pathways in intracellular signaling have been found for steroid hormones (Fig. 8) .
When stimulated with steroid hormones, target cells exhibited rapid intracellular signal changes in several seconds, indicating nongenomic signaling pathways corresponding to those in the cytosol. Receptors for steroid hormones were observed to function not only as transcription factors in the nucleus, but also as cytosolic signaling proteins, such as the direct interaction of tyrosine kinase (cSrc) with some target proteins, resulting in a change in cytosolic concentration levels of second messengers such as Ca 2+ and PIP3.
4·1·1 cGMP
It was found in 2001 that 17β-estradiol (E2)-loaded rat uterus exhibited a marked decrease in the expression level of soluble guanylate cyclase (sGC) that produces cGMP. 36 We also observed in human uterine smooth muscle tumor cells (SKN), using reverse transcription PCR, that the expression levels of both α and β subunits of sGC decreased in 24 h in an E2 concentration-dependent manner. In vascular endothelial cells, estrogen and thyroid hormones increased the PIP3 concentration and activate serine/threonine kinase Akt. 35 On the other hand, in the rat uterus, the expression of soluble guanylate cyclase was inhibited in 24 h, via a genomic pathway upon treating with 17β-estradiol (E2). 36 Fig . 9 A fluorescent probe molecule for cGMP. cGMP-dependent protein kinase (PKGIα) is used for selective recognition of cGMP. PKGIβ is structurally changed upon binding with cGMP, which is monitored by fluorescence resonance energy transfer (FRET) between two color mutants of GFPs, CFP and YFP, attached to Nand C terminals of PKGIα, respectively. This probe is called CGY after its molecular structure which consists of CFP, PKGIα and YFP, and is used to measure cGMP levels in living cells. 37 inhibitory effect on β subunit expression compared with E2.
In human SKN cells expressed with our fluorescent indicator CGY for visualizing cGMP 37 ( Fig. 9) , we further found this E2-dependent decrease in the sGC expression level as a decrease in cGMP generation observed under a fluorescence microscope. Other representative EDCs, such as bisphenol-A, genistein, and DES were also tested. This approach does not rely on exogenous reporter genes such as luciferase; thus endogenous sGC generation was monitored instead. This method may therefore become a more physiologically relevant "reporter gene assay" for the risk assessment of environmental estrogens. 38 This would be a kind of biomarker.
4·1·2 Calmodulin dependent protein kinase (CaMK)
Like many peptide hormones and neurotransmitters, 17β-estradiol (E2) was found to change intracellular Ca 2+ signals in a nongenomic manner, using an intracellular fluorescent Ca 2+ probe.
However, regarding some twenty Ca 2+ signaling molecules including kinases and phosphatases, we are ignorant as to when, where, and to what extent they are activated and functioning in a Ca 2+ -dependent manner. We, therefore, developed a fluorescent probe for imaging of activation of Ca 2+ -dependent serine/threonine kinase CaMK. This probe is a fusion protein consisting of CaMK that is inserted between two different color GFP variants, CFP and YFP. This molecule has been confirmed to retain the expected characteristics of wildtype CaMK in cells including its phosphorylation and structural change upon interaction with Ca 2+ /calmodulin. This molecule emits a fluorescent (FRET) signal in vivo, which reflects the extent of the activation of CaMK itself (Fig. 10) . 39 In estrogen-responsive human breast cancer cells (MCF-7), this CaMK-activation probe was expressed; the stimulation with 100 µM ATP led to CaMK activation, while 100 nM E2 did not cause CaMK activation. This indicates that E2 acts in a nongenomic manner to elevate the intracellular Ca 2+ level as determined by a Ca 2+ fluorescent indicator, but the elevated Ca 2+ concentration is not sufficient to activate the downstream CaMK route. On the other hand, 100 µM bisphenol-A stimulated more amplified and prolonged Ca 2+ transients compared with E2, resulting in transient and reproducible activation of CaMK. Other EDCs, e.g., 10 µM nonylphenol and 1 µM DES, also stimulated more amplified Ca 2+ transients compared with E2, while surprisingly, these EDCs did not cause any significant transients of CaMK activation. These results exemplify the significance of serial analysis of signaling events for screening of endocrine disrupters. Moreover, other Ca 2+ signaling routes are currently being examined.
4·1·3 Protein phosphorylation
Cellular signaling via protein phosphorylation cannot be missed during HTPS of EDCs. A general approach to direct detection of protein phosphorylation in live cells has been developed.
Custom-made fluorescent probes for protein phosphorylation (phocus) can be designed and constructed for any given pairs of phosphorylation recognition and substrate domains. As shown in Fig. 11 , a substrate domain of interest and a corresponding phosphorylation recognition domain are connected with a flexible linker peptide. CFP and YFP are attached as the flanking pieces of the probe protein. Upon phosphorylation of the substrate domain, the phosphorylation recognition domain is bound to the phosphorylated substrate, which results in a large structural change in the molecule, and generation of FRET.
The working principle of this probe molecule was confirmed with an insulin signaling system for quantitative imaging of tyrosine phosphorylation of an involved protein in living CHO-511 ANALYTICAL SCIENCES MAY 2002, VOL. 18 
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IR cells. 40 This focus was further tailored for detecting protein phosphorylation in nongenomic estrogen signaling pathways for use for EDCs screening.
To observe estrogen-induced activation of tyrosine kinase cSrc and serine/threonine kinase Akt/PKB, Src-phocus and Akt-phocus were developed, respectively, using suitable pairs of phosphorylation recognition and substrate domains. Now we are in the stage to evaluate the effect of EDCs on these nongenomic kinase signaling pathways.
4·1·4 Protein-protein interactions
Protein interactions in eukaryotic cells play requisite roles such as controlling enzymatic activities, gene expressions and protein phosphorylation/dephosphorylation. When a particular cell was stimulated with EDCs, homeostasis of the cellular signaling is disturbed and certain protein interactions may change. By monitoring this change in particular protein/protein interaction in a living cell, one can thereby evaluate the extent of possible adverse effects, if any, of EDCs. Like the other fluorescent probe molecules described above, it is significant that an HTPS method for EDCs based on protein interactions in living cells be developed.
The conventional approach of destructive analysis for evaluating the protein/protein interaction is not applicable for HTPS in which the number of EDC candidates is too large for batch-type destructive analysis. In view of these considerations, we have developed a new method for detecting protein-protein interaction based on protein splicing, in which the interactions are visualized in living cells.
In this detection system, a protein splicing system was used where an intervening protein of dnaE was excised and the flanking protein fragments were spliced together. Proteins whose interactions were being monitored are attached to the Nand C-terminal portions of dnaE and the green fluorescent protein (EGFP). When the proteins interact, the two portions of dnaE came sufficiently close together to fold and initiate protein splicing. The two halves of EGFP were ligated and released to fluoresce (Fig. 12) . [41] [42] [43] [44] Unlike earlier protein interaction assays, the split-GFP system involves the reconstitution of GFP, and does not require that the protein-protein interactions occur near the cell nucleus and reporter genes or that an enzyme substrate be present. This will 512 ANALYTICAL SCIENCES MAY 2002, VOL. 18 make the method generally more useful and will allow screening of the interactions in the cytosol or at the inner membrane level. This GFP splicing system was applied to EDCs screening using living eukaryotic cells. As an example, the interaction between the androgen receptor (AR) and cSrc is demonstrated in Fig. 13a . The male sex hormone androgen, dihydrotesterone (DHT), has been known to bind the androgen receptor (AR) in the cytosol, and induce cell proliferation. Furthermore, DHT increased the kinase activity of cSrc located adjacent to the cell membrane in the cytosol of prostate cancer cells and osteoblasts. On the basis of these findings, the N-and Cterminal halves of the split GFP probe were attached to cSrc and AR, respectively, and expressed in NIH3T3 cells.
Upon stimulation with DHT, the cells emitted GFP fluorescence, which indicates that DHT induced the interaction between cSrc and AR inside the cell membrane, and GFP was generated as a result (Fig. 13b) . Moreover, flow-cytometry (fluorescence-activated cell sorter, FACS) confirmed that the number of fluorescent cells increased with an increase in the DHT concentration (Fig. 13c) .
Furthermore, flutamide, an AR antagonist, decreased the number of fluorescent cells, indicating that cSrc-AR interaction was inhibited by flutamide (Fig. 13d) . 45 The split GFP system can thereby detect certain intracellular protein-protein interactions nondestructively in living cells. This assay system will therefore be used for EDC screening on the basis of a nongenomic pathway involving AR.
4·1·5 Nuclear imports
Protein trafficking into the nucleus plays an important role for efficient and rapid signal transduction from the plasma membrane to the nucleus. The communication between cytoplasm and nucleus is essential for the maintenance of homeostasis in living cells. Previous studies of intracellular localization of proteins have been performed by immunohistochemistry or immunocytochemistry using specific antibodies, which require fixing and killing the cells. In contrast, GFP that is fused to a protein of interest has enabled analysis of the dynamics of nuclear and cytoplasmic localization in response to different extracellular signals with spatial and temporal resolution. The use of these methods is, however, limited only to qualitative analysis.
The protein splicing system is a powerful approach to quantitatively assess the amount of a protein located in the nucleus. The concept is shown in Fig. 14 . Androgen receptor is used as a target, which is attached to the N-terminal half of DnaE and luciferase. The C-terminal half of the DnaE is connected with a short amino acid sequence referred to as a nuclear localization signal (NLS). The NLS allows the Cterminal probe molecule to reside in the nucleus. When the cell is stimulated with androgen, its receptor translocates into the nucleus and approximates to the C-terminal probes in the narrow nuclear compartment. Since the N-and C-terminal halves of DnaE have an affinity to some extent, luciferase formation following splicing reaction proceeds. The luminescence intensity of thus formed matured luciferase was found to be proportional to the amount of androgen receptor that translocates to the nucleus. 46 There will be numerous other applications in this system to the quantitative detection of a localized protein such as in the mitochondria or endoplasmic reticulum. 47 A new method was demonstrated for imaging conformational changes of proteins in live cells using a new synthetic environment-sensitive fluorescent probe, 9-amino-6,8-bis(1,3,2-dithioarsolan-2-yl)-5H-benzo[a]phenoxazin-5-one. This fluorescent probe can be attached to recombinant proteins containing four cysteine residues at the i, i + 1, i + 4, i + 5 positions of an α-helix, as illustrated in Fig. 15 . The specific binding of the fluorescent probe to this 4Cys-motif enables fluorescent labeling inside cells by its extracellular administration. The high sensitivity of the fluorophore to its environment enables monitoring of the conformational changes of the proteins in live cells as changes in its fluorescence intensity. The present method was applied to calmodulin (CaM), a Ca 2+ -binding protein, which was well known to expose hydrophobic domains depending on Ca 2+ concentration. A recombinant CaM fused at its C-terminal with a helical peptide containing a 4Cys-motif was labeled with the fluorescent probe inside live cells. The fluorescence intensity changed reversibly depending on intracellular Ca 2+ concentration, which reflected 513 ANALYTICAL SCIENCES MAY 2002, VOL. 18 IgE is produced in mammalian blood against various types of antigens, and it causes typical immediate-type hypersensitivity like asthma, atopic dermatitis and food allergies. Dust mites, molds and tree pollens are known to be major allergens for asthma. Ovalbumin, milk and soybeans are major allergens for food allergies.
4·2 Protein conformational changes
Furthermore, penicillin or other small compounds (i.e. trimellitic anhydride, toluene diisocyanate) are shown to produce IgEs and cause anaphylaxis.
Mast cells, such as rat basophilic leukemia (RBL) cells and bone-marrow derived mast cells (BMMCs), bear FcεRIs on the cell surface, and the Fc portion of IgE can specifically be captured by this receptor. FcεRIs are expressed primarily by mast cells and basophils, and these cells play a critical role in the immediate-type hypersensitivity. Figure 16 shows the signal transduction scheme in mast cells. When a particular multivalent antigen associates with two neighboring IgE bound FcεRI units, it crosslinks these two complexes on the cell membrane (a). The importance of this receptor crosslinking has widely been recognized as the first step for the intracellular signal transduction. The resulting phosphorylation of FcεRI initiates an increase in concentrations of sphingosine-1-phosphate and IP3. Sphingosine-1-phosphate and IP3 cause the calcium signal (b) to trigger. This calcium ion mobilization is one of the earliest and most important events in the intracellular signal transduction in mast cells. The release of Ca 2+ from the intracellular calcium storage site (i.e. endoplasmic reticulum) is generated (c -1), and the influx of Ca 2+ through the calciumrelease-activated calcium (CRAC) channel is induced (c -2). The sustained increase in [Ca 2+ ]i (c) promotes the release into the extracellular space (d, e) of mediators for immediate hypersensitivity from cytoplasmic secretory granules upon its degranulation. Such a sustained intracellular Ca 2+ mobilization is indispensable for this degranulation. Of such mediators, histamine, β-hexosaminidase and serotonin contained in the secretory granules are important in eliciting symptoms associated with allergic reactions.
We proposed a new, convenient and time-saving screening method for the determination of IgEs in the serum based on intracellular Ca 2+ signal transduction in mast cells. Using celllined RBL-2H3 cells and primary cultured mouse BMMCs, we found that [Ca 2+ ]i can be a 1:1 probe for the concentration of IgE in the mouse serum sample. The principle of the proposed method for the screening of the antigen-specific IgE in the serum is schematically shown in Fig. 17 . Upon addition of the 514 ANALYTICAL SCIENCES MAY 2002, VOL. 18 serum containing various antigen-specific IgEs to the cell suspension, these antigen-specific IgEs are each captured by a single FcεRI on the cell surface. When the screening of OVAspecific IgE in the serum is then required, for example, the ovalbumin (OVA)-specific IgE bound to FcεRI can selectively be picked up by adding its antigen OVA to crosslink the two neighboring identical receptor-antibody complexes on the cell surface. The intracellular Ca 2+ signal is thereby provoked; it is finally detected as an analytical measure for the target IgE level in the sample serum. Although various antigen-specific IgEs are generally contained in the serum, one desired antigenspecific IgE can thus specifically be detected by the present method.
The very small percentage in the serum of the target IgE in comparison with its counterpart IgG does not prevent the measurement of the IgE, in the proposed assay because FcεRI can specifically bind to IgE, and this is one of the important advantages over ELISA. Because ELISA is a binding assay, the antigen-specific IgE in the serum binds to the antigen adsorbed on the plate regardless of whether the antigen is multivalent or not. However, in mast cells, the monovalent antigen without crosslinking of receptors cannot induce the intracellular signal transduction. Only a specific IgE that evokes hypersensitivity can thus be determined. 49 
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